Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation
Open Access
- 1 March 2004
- journal article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 10 (3), 178-185
- https://doi.org/10.1016/j.bbmt.2003.10.006
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortalityBlood, 2001
- Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effectsBlood, 2001
- Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantationBlood, 2001
- Role of tumor necrosis factor-alpha inhibition with inflixiMAB in cancer therapy and hematopoietic stem cell transplantationCurrent Opinion in Oncology, 2000
- Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapyBritish Journal of Haematology, 2000
- The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantationBlood, 2000
- Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantationBone Marrow Transplantation, 1999
- A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatmentBlood, 1991
- A retrospective analysis of therapy for acute graft-versus-host disease: initial treatmentBlood, 1990
- Graft-Versus-Host DiseaseHematology/Oncology Clinics of North America, 1990